Skip to main content
Premium Trial:

Request an Annual Quote

BC Platforms, Genomenon Team on Analytics for Rare Disease Dx, Research

NEW YORK – BC Platforms and Genomenon said Tuesday that they have agreed to combine their technologies for rare disease diagnostics and research.

The collaboration calls on Genomenon to integrate its Mastermind genomic search engine into two BC Platforms products: the BC|Genome genomic interpretation and analysis platform to support molecular diagnostics and other forms of clinical genomics; and discovery and insight system BC|Insight on the research side. Mastermind accelerates variant interpretation with the help of machine learning.

"Genomenon is a natural partner for us, as both companies are passionate about powering evidence-based genomics," BC Platforms CEO Tero Silvola said in a statement. "This is about super-charging data-driven decision-making in healthcare."

Further terms of the alliance were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.